Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2022 2
2023 1
2025 1
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
[The Lifestyle Monitor: prevalence rates for health policy].
de Hollander E, Hupkens C, van Dorsselaar S, Wendel-Vos W, Kemler E, de Graaf H, Stafleu A, Hosper K, Tak N, van Rossum C, Vermey K, Hiemstra M. de Hollander E, et al. Among authors: vermey k. TSG. 2022;100(3):98-106. doi: 10.1007/s12508-022-00349-8. Epub 2022 May 13. TSG. 2022. PMID: 35582661 Free PMC article. Dutch.
Online-Mediated HIV Pre-exposure Prophylaxis Care and Reduced Monitoring Frequency for Men Who Have Sex With Men: Protocol for a Randomized Controlled Noninferiority Trial (EZI-PrEP Study).
Groot Bruinderink ML, Boyd A, Coyer L, Boers S, Blitz L, Brand JM, Götz HM, Stip M, Woudstra J, Yap K, Vermey K, Matser A, Feddes AR, Jongen VW, Prins M, Hoornenborg E, van Harreveld F, Schim van der Loeff MF, Davidovich U. Groot Bruinderink ML, et al. Among authors: vermey k. JMIR Res Protoc. 2023 Nov 8;12:e51023. doi: 10.2196/51023. JMIR Res Protoc. 2023. PMID: 37938875 Free PMC article.
Representativeness of participants in a randomized controlled trial on modalities of monitoring oral HIV pre-exposure prophylaxis use.
Groot Bruinderink ML, Schim Van Der Loeff MF, Dusseldorp F, Van Der Velde K, Blitz L, Brand JM, Van Bokhoven C, Woudstra J, Vermey K, Boers S, Sluimer M, Götz HM, Boyd A, Werner L, Soors d'Ancona ML, Van Harreveld F, Prins M, Hoornenborg E, Davidovich U, Jongen VW. Groot Bruinderink ML, et al. Among authors: vermey k. AIDS Res Ther. 2026 Apr 13;23(1):68. doi: 10.1186/s12981-026-00886-1. AIDS Res Ther. 2026. PMID: 41975506 Free PMC article. Clinical Trial.
Impact of reduced-frequency monitoring among users of HIV pre-exposure prophylaxis on sexually transmitted infections and associated care: secondary outcomes of a randomized controlled trial.
Wijstma ES, Groot Bruinderink ML, Jongen VW, Boyd AC, Blitz L, van Bokhoven C, Woudstra J, Vermey K, Boers S, Götz HM, van Harreveld F, Prins M, Hoornenborg E, Davidovich U, Schim van der Loeff MF. Wijstma ES, et al. Among authors: vermey k. BMC Med. 2026 Jun 4. doi: 10.1186/s12916-026-04949-y. Online ahead of print. BMC Med. 2026. PMID: 42243843 Free article.